2026 NPPES data Optometrist NPI 1124028782
Verify on CMS →

GEORGE SYMONDS

Optometrist in PORT ANGELES, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
474
Medicare Part D claims · 115 beneficiaries · Optometrist avg: 257
Generic prescribing
60%
generic claims · 40% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
12.5618/100
▼ 71 pts below national avg 83.1 · [object Object]

What the federal data shows

GEORGE SYMONDS reported a CMS MIPS final score of 12.5618/100 — below the 83.1 national average — and filed 474 Medicare Part D claims in 2023.

12.5618/100
MIPS score · -71 vs avg
474
Part D claims, 2023
60%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GEORGE SYMONDS's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

13 2nd percentile higher than 2% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). This entry sits in this band. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about GEORGE SYMONDS?

Below national average

NPI registry status

Active

Issued 07/26/2005

NPI 1124028782

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

474 84% vs specialty avg

2023 prescription claims

Specialty avg: 257

MIPS final score

12.5618/100 70.53819999999999% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in Washington

How Optometrist compares to other specialties among Washington providers

Washington providers

Optometrist share within Washington

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within Washington

Medicare quality performance — MIPS

GEORGE SYMONDS's 2023 MIPS final score plotted against the Optometrist national average

Below national average
MIPS Final Score
12.5618/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Optometrist) — 12.5618/100 vs national avg 83.1

0%100%National avg83%12.6%
MIPS final score (Optometrist) — 12.5618/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GEORGE SYMONDS appears in the CMS NPPES registry as a Optometrist provider at 1122 E FRONT ST, PORT ANGELES, WA, 98362, with a listed phone of (360) 457-1161. NPI 1124028782 was issued on 07/26/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SYMONDS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 474 prescription claims written by this provider, covering 115 Medicare beneficiaries and totaling roughly $108K in drug spend, split 40% brand-name and 60% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 12.5618/100 for the 2023 performance year (Quality 25.1235), compared with the national average of 83.1.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1122 E FRONT ST
PORT ANGELES, WA 98362

Provider Details

NPI 1124028782
Specialty Optometrist
Gender Male
NPI Issued 07/26/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

12.5618
Final Score
Avg: 83.1
25.1235
Quality

Reporting: Individual

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to GEORGE SYMONDS. To verify GEORGE SYMONDS's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

GEORGE SYMONDS — brand share 40.0%
Specialty average (est.)

40% brand-name claims vs 60% generic, on 474 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

474
Total Claims
$108K
Total Drug Cost
115
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
835
Total Day Supply
23,906
Brand vs Generic
40% brand / 60% generic
Brand Drug Cost
$99K
Generic Drug Cost
$9K

Patient Demographics

Average Patient Age
76.8 years
Avg HCC Risk Score
0.99
Gender Split
70% female / 30% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What GEORGE SYMONDS prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
196
Timolol Maleate
52
Restasis
Cyclosporine
41
Travoprost
26
Lumigan
Bimatoprost
22
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
19
Combigan
Brimonidine Tartrate/Timolol
17
Erythromycin
Erythromycin Base
15
Azopt
Brinzolamide
12
Xiidra
Lifitegrast
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How GEORGE SYMONDS fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

GEORGE SYMONDS's 474 claims are above the specialty average of 257.

Nearby Optometrist Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as SYMONDS.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is GEORGE SYMONDS's specialty?
GEORGE SYMONDS specializes in Optometrist and practices in PORT ANGELES, Washington.
How much does GEORGE SYMONDS prescribe under Medicare Part D?
In 2023, GEORGE SYMONDS wrote 474 Medicare Part D claims totaling $108K in drug costs for 115 beneficiaries.
What is GEORGE SYMONDS's Medicare quality score?
GEORGE SYMONDS has a CMS MIPS Final Score of 12.5618/100 (Quality: 25.1235). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is GEORGE SYMONDS located?
GEORGE SYMONDS is located at 1122 E FRONT ST, PORT ANGELES, WA, 98362. Phone: (360) 457-1161.
What is GEORGE SYMONDS's NPI number?
GEORGE SYMONDS's National Provider Identifier (NPI) is 1124028782, issued on 07/26/2005.
Does GEORGE SYMONDS prescribe more brand-name or generic drugs?
GEORGE SYMONDS's prescribing is 40% brand-name and 60% generic drugs by claim count, with $99K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does GEORGE SYMONDS prescribe most often?
Based on 2023 Medicare Part D data, GEORGE SYMONDS's most frequently prescribed drugs include Latanoprost, Timolol Maleate, Restasis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GEORGE SYMONDS accept Medicare?
GEORGE SYMONDS appears in CMS Medicare data with 474 Part D claims and 115 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GEORGE SYMONDS's credentials?
GEORGE SYMONDS's NPI is 1124028782. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology